PINDOLOL

Post-LOESM

pindolol

Teva

ANDAORALTABLET

Approved

Feb 1993

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

5/8 — Partial

PINDOLOL (pindolol) by Teva is clinical pharmacology pindolol is a nonselective beta-adrenergic antagonist (beta-blocker) which possesses intrinsic sympathomimetic activity (isa) in therapeutic dosage ranges but does not possess quinidine-like membrane stabilizing activity. Approved for the management of hypertension. First approved in 1993.

Drug data last refreshed 21h ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY Pindolol is a nonselective beta-adrenergic antagonist (beta-blocker) which possesses intrinsic sympathomimetic activity (ISA) in therapeutic dosage ranges but does not possess quinidine-like membrane stabilizing activity.

Indications (1)

the management of hypertension

Clinical Trials (4)

NCT07101939Phase 2Recruiting

A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)

Started Jun 2025

120 enrolled

ObesityMuscle Loss

NCT06028321Phase 1Completed

Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)

Started Nov 2021

51 enrolled

Cachexia

NCT01219686Phase 2/3Terminated

EScitalopram PIndolol ONset of Action

Started Oct 2010

18 enrolled

Unipolar Depression

NCT00159146N/ATerminated

Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Started Aug 2002

31 enrolled

Major Depression

Worked on PINDOLOL at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.